ATAI vs XLV
ATAI Life Sciences BV (ATAI) versus Health Care Select Sector SPDR® Fund (XLV) — a side-by-side from cached financials, not a winner call.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
Health Care Select Sector SPDR® Fund (XLV) common stock listed on US.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
XLV does not have a complete income-statement cache yet.
ATAI currently screens at market cap $555.8M. XLV currently screens at market cap $0.
Not investment advice. Open the ATAI and XLV stock pages for the full models.
Not investment advice.